journal article·2014-11

Induction of long-term immunity against respiratory syncytial virus glycoprotein by an osmotic polymeric nanocarrier

Jannatul Firdous, Mohammad Ariful Islam, Sung-Moo Park, In-Su Cheon, Byoung-Shik Shim, Hyo-Shin Yoon, Manki Song, Jun Chang, Yun-Jaie Choi, Yeong-Min Park, Diana Boraschi, Seung-Hyun Han, Chong-Su Cho, Cheol-Heui Yun

Acta Biomaterialia· Volume 10· Issue 11
Publisher page

Abstract

Respiratory syncytial virus (RSV) is one of the most common causes of viral deaths in infants worldwide, yet no effective vaccines are available. Here, we report an osmotically active polysaccharide-based polysorbitol transporter (PST) prepared from sorbitol diacrylate and low-molecular-weight polyethylenimine (PEI) showing a potent, yet safe, adjuvant activity and acting as an effective delivery tool for RSV glycoprotein (RGp) antigen. PST showed no toxicity in vitro or in vivo, unlike PEI and the well-known experimental mucosal adjuvant cholera toxin (CT). PST formed nano-sized complexes with RGp by simple mixing, without affecting antigenic stability. The complexes exhibited negative surface charges that made them highly efficient in the selective activation of phagocytic cells and enhancement of phagocytic uptake. This resulted in an improved cytokine production and in the significant augmentation of RGp-specific antibody production, which persisted for over 200 days. Interestingly, PST/RGp enhanced phagocytic uptake owing to the osmotic property of PST and its negative zeta potential, suggesting that PST could selectively stimulate phagocytic cells, thereby facilitating a long-lived antigen-specific immune response, which was presumably further enhanced by the polysaccharide properties of PST.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Respiratory viral infections research · Pneumonia and Respiratory Infections · Neonatal Respiratory Health Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (53)

Show source-provided references
1. Respiratory syncytial virus market10.1038/nrd3075 ↗
2. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 710.1164/ajrccm.161.5.9906076 ↗
3. Asthma and immunoglobulin-E antibodies after respiratory syncytial virus bronchiolitis-a prospective cohort study with matched controls10.1542/peds.95.4.500 ↗
4. Respiratory syncytial virus infections in previously healthy working adults10.1086/322657 ↗
5. Repeated infections with respiratory syncytial virus10.4049/jimmunol.98.6.1115 ↗
6. Risk of primary infection and reinfection with respiratory syncytial virus
7. Immunity to and frequency of reinfection with respiratory syncytial virus10.1093/infdis/163.4.693 ↗
8. Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma10.1038/nm.2896 ↗
9. Pharmacotherapy of respiratory syncytial virus infection10.1016/j.coph.2010.04.013 ↗
10. Immunoprophylaxis of RSV infection: advancing from RSV-IGIV to palivizumab and motavizumab
11. Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein10.1128/JVI.00447-10 ↗
12. Emerging drugs for respiratory syncytial virus infection10.1517/14728210902946399 ↗
13. Palivizumab-resistant human respiratory syncytial virus infection in infancy10.1086/653534 ↗
14. Identification of nucleolin as a cellular receptor for human respiratory syncytial virus10.1038/nm.2444 ↗
15. A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus10.1073/pnas.0912186107 ↗
16. Antiviral and lung protective activity of a novel respiratory syncytial virus fusion inhibitor in a mouse model10.1183/09031936.00005610 ↗
17. CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein10.1038/90675 ↗
18. Vaccine manufacturing: challenges and solutions10.1038/nbt1261 ↗
19. An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice10.1016/j.vaccine.2010.12.031 ↗
20. Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens10.1038/nbt.2344 ↗
21. Syndecan-1 mediates the coupling of positively charged submicrometer amorphous silica particles with actin filaments across the alveolar epithelial cell membrane10.1016/j.taap.2009.01.022 ↗
22. Effect of glucose concentration, osmolality, and sterilization process of peritoneal dialysis fluids on cytokine production by peripheral blood mononuclear cells and polymorphonuclear cell functions in vitro10.1053/ajkd.1998.v31.pm9469498 ↗
23. Hyperosmotic stress enhances cytokine production and decreases phagocytosis in vitro10.1186/cc6989 ↗
24. The effect of hyperosmotic pressure on antibody production and gene expression in the GS-NS0 cell line10.1042/BA20030170 ↗
25. Accelerated gene transfer through a polysorbitol-based transporter mechanism10.1016/j.biomaterials.2011.09.013 ↗
26. High gene transfer by the osmotic polysorbitol-mediated transporter through the selective caveolae endocytic pathway10.1021/mp300072r ↗
27. The role of osmotic polysorbitol-based transporter in RNAi silencing via caveolae-mediated endocytosis and COX-2 expression10.1016/j.biomaterials.2012.08.049 ↗
28. The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response10.4049/jimmunol.180.4.2165 ↗
29. Evaluation of protective efficacy of respiratory syncytial virus vaccine against A and B subgroup human isolates in Korea10.1371/journal.pone.0023797 ↗
30. Acute osmotic stress affects Tilapia (Oreochromis mossambicus) innate immune responses10.1016/j.fsi.2008.09.006 ↗
31. Effects of serum on phagocytic activity and proteomic analysis of tilapia (Oreochromis mossambicus) serum after acute osmotic stress10.1016/j.fsi.2009.03.005 ↗
32. Effect of hypoosmotic pressure on cell growth and antibody production in recombinant Chinese hamster ovary cell culture10.1023/A:1014032701800 ↗
33. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus10.1073/pnas.0608611104 ↗
34. Diffusion of macromolecules and virus-like particles in human cervical mucus10.1016/S0006-3495(01)75844-4 ↗
35. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles10.1016/j.biomaterials.2010.01.065 ↗
36. 2012 · 215
37. Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats10.1016/S0939-6411(98)00038-1 ↗
38. Role of surface charge and oxidative stress in cytotoxicity of organic monolayer-coated silicon nanoparticles towards macrophage NR8383 cells10.1186/1743-8977-7-25 ↗
39. Probing insulin’s secondary structure after entrapment into alginate/chitosan nanoparticles10.1016/j.ejpb.2006.09.005 ↗
40. A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants10.1016/S0264-410X(02)00155-X ↗
41. A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy10.1016/j.ymthe.2005.02.010 ↗
42. Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages-suppression of early cytokine production and implications for incomplete immunity10.1172/JCI118302 ↗
43. Persistence of antibodies in laboratory staff immunized with quadrivalent meningococcal polysaccharide vaccine10.1186/1745-6673-8-4 ↗
44. T-independent type II immune responses generate memory B cells10.1084/jem.20052036 ↗
45. Long-term maintenance of polysaccharide-specific antibodies by IgM-secreting cells10.4049/jimmunol.1100783 ↗
46. Characterization of B cell membrane receptors of polysaccharide isolated from the root of Acanthopanax koreanum10.1016/S1567-5769(03)00056-0 ↗
48. Effect of osmolar and ionic composition of the extracellular fluid on transferrin endocytosis and exocytosis and iron uptake by reticulocytes10.1002/jcp.1041340102 ↗
49. Biodegradable nanoparticles as vaccine adjuvants and delivery systems: regulation of immune responses by nanoparticle-based vaccine10.1007/12_2011_150 ↗
50. 2005 · 66
51. Intracellular delivery of a protein antigen with an endosomal-releasing polymer enhances CD8 T-cell production and prophylactic vaccine efficacy10.1021/bc100204m ↗
52. Innate immunity: impact on the adaptive immune response10.1016/S0952-7915(97)80152-5 ↗
53. The love-hate relationship between bacterial polysaccharides and the host immune system10.1038/nri1956 ↗